{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:59:10Z","timestamp":1785862750773,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008302","name":"Department of Education and Learning, Northern Ireland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008302","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001632","name":"University of Ulster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.mce.2014.10.025","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T14:39:15Z","timestamp":1415284755000},"page":"120-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice"],"prefix":"10.1016","volume":"401","author":[{"given":"V.","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.A.","family":"Gault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2014.10.025_bib0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1530\/acta.0.1120224","article-title":"Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob\/ob) mice fed high fat and high carbohydrate cafeteria diets","volume":"112","author":"Bailey","year":"1986","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.mce.2014.10.025_bib0015","series-title":"Gut Peptides: Biochemistry and Physiology","first-page":"765","article-title":"Enteroinsular axis","author":"Brown","year":"1994"},{"issue":"S1","key":"10.1016\/j.mce.2014.10.025_bib0020","first-page":"A482","article-title":"A reappraisal of antagonists for the human glucose-dependent insulinotropic polypeptide (GIP) receptor","volume":"61","author":"Christensen","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2014.10.025_bib0025","first-page":"E468","article-title":"GIP 3\u201342 does not antagonize the insulinotropic effects of GIP at physiological concentrations","volume":"291","author":"Deacon","year":"2006","journal-title":"Am. J. Physiol"},{"key":"10.1016\/j.mce.2014.10.025_bib0030","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/pro.5560040708","article-title":"N- and C-capping preferences for all 20 amino acids in alpha-helical peptides","volume":"4","author":"Doig","year":"1995","journal-title":"Protein Sci"},{"key":"10.1016\/j.mce.2014.10.025_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI30076","article-title":"The role of gut hormones in glucose homeostasis","volume":"117","author":"Drucker","year":"2007","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.mce.2014.10.025_bib0040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","article-title":"Abnormal plasma glucose and insulin responses in heterozygous (ob\/+) mice","volume":"20","author":"Flatt","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2014.10.025_bib0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2337\/diab.32.5.433","article-title":"Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice","volume":"32","author":"Flatt","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2014.10.025_bib0050","first-page":"23","article-title":"Effects of diets rich in sucrose, coconut fat and safflower seed oil on the development of the obese hyperglycaemic (ob\/ob) syndrome in mice","volume":"13","author":"Flatt","year":"1990","journal-title":"Diabetes Res"},{"key":"10.1016\/j.mce.2014.10.025_bib0055","doi-asserted-by":"crossref","first-page":"e3163","DOI":"10.1371\/journal.pone.0003163","article-title":"Vaccination against GIP for the treatment of obesity","volume":"3","author":"Fulurija","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mce.2014.10.025_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.npep.2003.09.002","article-title":"Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential","volume":"37","author":"Gault","year":"2003","journal-title":"Neuropeptides"},{"key":"10.1016\/j.mce.2014.10.025_bib0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00125-002-1028-x","article-title":"Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob\/ob) mice: evidence that GIP is the major physiological incretin","volume":"46","author":"Gault","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2014.10.025_bib0070","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.2337\/diabetes.54.8.2436","article-title":"Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes","volume":"54","author":"Gault","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2014.10.025_bib0075","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s00125-007-0710-4","article-title":"Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diet","volume":"50","author":"Gault","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2014.10.025_bib0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1515\/BC.2007.019","article-title":"Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes","volume":"388","author":"Gault","year":"2007","journal-title":"Biol. Chem"},{"key":"10.1016\/j.mce.2014.10.025_bib0085","first-page":"265","article-title":"Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high-fat fed mice","volume":"208","author":"Gault","year":"2011","journal-title":"J. Endocrinol"},{"key":"10.1016\/j.mce.2014.10.025_bib0090","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00125-009-1422-8","article-title":"Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications","volume":"52","author":"Irwin","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2014.10.025_bib0095","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.coph.2013.09.009","article-title":"Enteroendocrine hormone mimetics for the treatment of obesity and diabetes","volume":"13","author":"Irwin","year":"2013","journal-title":"Curr. Opin. Pharmacol"},{"key":"10.1016\/j.mce.2014.10.025_bib0100","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00125-007-0692-2","article-title":"Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob\/ob mice","volume":"50","author":"Irwin","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2014.10.025_bib0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/BC.2009.002","article-title":"Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes","volume":"390","author":"Irwin","year":"2009","journal-title":"Biol. Chem"},{"key":"10.1016\/j.mce.2014.10.025_bib0110","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/13543784.2010.513381","article-title":"Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?","volume":"9","author":"Irwin","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.mce.2014.10.025_bib0115","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbrc.2010.12.077","article-title":"Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptide","volume":"404","author":"Kerr","year":"2011","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.mce.2014.10.025_bib0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bone.2014.02.013","article-title":"Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties","volume":"63","author":"Mabilleau","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.mce.2014.10.025_bib0125","doi-asserted-by":"crossref","first-page":"E1746","DOI":"10.1152\/ajpendo.00460.2007","article-title":"GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet","volume":"293","author":"McClean","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab"},{"key":"10.1016\/j.mce.2014.10.025_bib0130","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bjp.2008.317","article-title":"(Pro3)GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy","volume":"155","author":"McClean","year":"2008","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.mce.2014.10.025_bib0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1677\/joe.0.1510349","article-title":"Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic B-cell line","volume":"151","author":"McClenaghan","year":"1996","journal-title":"J. Endocrinol"},{"key":"10.1016\/j.mce.2014.10.025_bib0140","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nat. Med"},{"key":"10.1016\/j.mce.2014.10.025_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbrc.2008.08.052","article-title":"Inhibition of GIP signaling modulates adiponectin levels under high-fat diet in mice","volume":"376","author":"Naitoh","year":"2008","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.mce.2014.10.025_bib0150","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.2337\/db13-1563","article-title":"Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high fat diet condition","volume":"63","author":"Nasteska","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2014.10.025_bib0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1079\/BJN19910024","article-title":"The effect of energy source and feeding level on the hormones of the entero-insular axis and plasma glucose in the growing pig","volume":"66","author":"Ponter","year":"1991","journal-title":"Br. J. Nutr"},{"key":"10.1016\/j.mce.2014.10.025_bib0160","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejphar.2010.10.059","article-title":"Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice","volume":"15","author":"Porter","year":"2011","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.mce.2014.10.025_bib0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.regpep.2012.12.012","article-title":"The C-terminal extension of exendin 4 provides additional metabolic stability when added to GLP-1, while there is minimal effect of truncating exendin-4 in anaesthetized pigs","volume":"10","author":"Simonsen","year":"2013","journal-title":"Regul. Pept"},{"key":"10.1016\/j.mce.2014.10.025_bib0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/dom.12181","article-title":"A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents","volume":"16","author":"Tartarkiewicz","year":"2014","journal-title":"Diabetes Obes. Metab"},{"key":"10.1016\/j.mce.2014.10.025_bib0175","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2337\/db12-0272","article-title":"Outstanding Scientific Achievement Award Lecture 2011: defeating diabesity. The case for personalized combinatorial therapies","volume":"61","author":"Tsch\u00f6p","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2014.10.025_bib0180","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00254497","article-title":"Peptides and the control of meal size","volume":"20","author":"Woods","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2014.10.025_bib0185","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbrc.2005.07.164","article-title":"Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action","volume":"335","author":"Zhou","year":"2005","journal-title":"Biochem. Biophys. Res. Commun"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720714003360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720714003360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T23:42:42Z","timestamp":1565998962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720714003360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":36,"alternative-id":["S0303720714003360"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2014.10.025","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2014.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}